Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04922_nanopub.RAkV7LXYg649u9TAXVXKbZVwIvjQKe0S3E9_mjYBv60ww#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB04922 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04922 label "XP13512 [drugbank:DB04922]" assertion.
- drugbank:DB04922 seeAlso DB04922 assertion.
- drugbank:DB04922 description "XP13512 is a patented new chemical entity internally discovered at XenoPort. It is in clinical development for the potential treatment of restless legs syndrome, or RLS, and neuropathic pain. It is a Transported Prodrug of gabapentin, a drug that has been sold by Pfizer Inc as Neurontin since 1993 and is currently sold as a generic drug by a number of companies. XP13512 is being investigated by XenoPort, Inc." assertion.
- drugbank:DB04922 identifier "drugbank:DB04922" assertion.
- drugbank:DB04922 title "XP13512" assertion.
- drugbank:DB04922 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB04922 drugbank_vocabulary:drugbank-id "DB04922" assertion.
- drugbank:DB04922 bio2rdf_vocabulary:x-identifiers.org DB04922 assertion.
- drugbank:DB04922 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04922" assertion.
- drugbank:DB04922 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04922 bio2rdf_vocabulary:identifier "DB04922" assertion.